Cite
HARVARD Citation
Zanotto-Filho, A. et al. (2018). Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer letters. pp. 101-115. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zanotto-Filho, A. et al. (2018). Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer letters. pp. 101-115. [Online].